VeriSIM Life announces U.S. government agreement on drug development methods
The company said it entered an agreement with the Department of War to advance computational new approach methodologies for medical countermeasure development and safety assessment. The work will use its BIOiSIM platform to evaluate models that could reduce animal studies and support study design.